Stay updated with breaking news from Nasdaq Fdmt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) shares gapped up prior to trading on Tuesday . The stock had previously closed at $15.99, but opened at $16.58. 4D Molecular Therapeutics shares last traded at $15.66, with a volume of 167 shares traded. Several research firms recently weighed in on FDMT. SVB Leerink began coverage […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) – Investment analysts at SVB Leerink issued their FY2023 EPS estimates for 4D Molecular Therapeutics in a research report issued to clients and investors on Tuesday, March 29th. SVB Leerink analyst M. Foroohar anticipates that the company will post earnings per share of ($2.58) for the year. […]
4D Molecular Therapeutics (NASDAQ:FDMT – Get Rating) announced its quarterly earnings results on Monday. The company reported ($0.85) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.86) by $0.01, Fidelity Earnings reports. Shares of NASDAQ FDMT traded down $0.86 during trading hours on Wednesday, hitting $15.49. 157,562 shares of the company’s stock […]
EMERYVILLE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing...
EMERYVILLE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing the...